Terephthalamide-containing ligands: Fast removal of iron from transferrin

Journal of Biological Inorganic Chemistry

Volumn 13, Issue 2, 2008, Pages 229-240

  Abergel, Rebecca J ^a   Raymond, Kenneth N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hydroxypyridinone; Iron chelation; Kinetics; Terephthalamide; Transferrin

Indexed keywords

2,3 DIHYDROXYTEREPHTHALAMIDE; IRON; LIGAND; METHYL 2,3 HYDROXYPYRIDINONE; TRANSFERRIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; GEL ELECTROPHORESIS; IRON BINDING CAPACITY; IRON CHELATION; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

AMIDES; BINDING, COMPETITIVE; CATECHOLS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IRON; IRON CHELATING AGENTS; KINETICS; LIGANDS; PHTHALIC ACIDS; PYRIDONES; SPECTROPHOTOMETRY, ULTRAVIOLET; SUBSTRATE SPECIFICITY; TRANSFERRIN;

EID: 38649110468     PISSN: 09498257     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00775-007-0314-y     Document Type: Article

References (58)

1. Lippard SJ, Berg JM (eds) (1994) Principles of bioinorganic chemistry. University Science Books, Mill Valley
2. Koppenol WH (2000) In: Badman DG, Bergeron RJ, Brittenham GM (eds) Iron chelators: new development strategies. The Saratoga Group, Ponte Vedra Beach, pp 3-10
3. Andrews NC (2000) Rev Clin Exp Hematol 4:283-301
4. Ponka P (1999) Kidney Int 55:S2-S11
5. Liu XF, Theil EC (2005) Acc Chem Res 38:167-175
6. Dertz EA, Raymond KN (2003) In: McCleverty J, Meyer T (eds) Comprehensive coordination chemistry II. Pergamon, Oxford, pp 141-168
7. Baker EN (1994) Adv Inorg Chem 41:389-463
8. Harris DC, Aisen P (1989) In: Loehr T (ed) Iron carriers and iron proteins. VCH, New York, pp 239-352
9. Otto B, Verweij-van Vught A, Maclaren D (1992) Crit Rev Microbiol 18:217-233
10. Pietrangelo A (2004) N Engl J Med 350:2383-2397
11. Thein SL (2004) Br J Haematol 124:264-274
12. Ballas SK (2002) Drugs 62:1143-1172
13. Olivieri NF, Brittenham GM (1997) Blood 89:739-761
14. Olivieri NF (2001) Semin Hematol 38:57-62
15. Porter JB, Huehns ER, Hider RC (1989) Baillieres Clin Haematol 2:257-292
16. Kontoghiorghes GJ, Pattichi K, Hadjigavriel M, Kolnagou A (2000) Transfus Sci 23:211-223
17. Kalinowski DS, Richardson DR (2005) Pharmaco Rev 57:547-583
18. O'Sullivan B, Xu J, Raymond Kenneth N (2000) In: Badman DG, Bergeron RJ, Brittenham GM (eds) Iron chelators: new development strategies. The Saratoga Group, Ponte Vedra Beach, pp 177-208
19. Hider RC, Zhou T (2005) Ann N Y Acad Sci 1054:141-154
20. O'Sullivan B, Xu J, Raymond KN (2000) In: Badman DG, Bergeron RJ, Brittenham GM (eds) Iron chelators: new development strategies. The Saratoga Group, Ponte Vedra Beach, pp 177-208
21. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D (2006) Blood 107:3455-3462
22. Motekaitis RJ, Martell AE (1991) Inorg Chim Acta 183:71-80
23. Pippard MJ (1994) In: Bergeron RJ, Brittenham GM (eds) The development of iron chelators for clinical use. CRC, Boca Raton, pp 57-74
24. Abergel RJ, Raymond KN (2006) Inorg Chem 45:3622-3631
25. Jurchen KMC, Raymond KN (2005) J Coord Chem 58:55-80
26. Jurchen KMC, Raymond KN (2006) Inorg Chem 45:1078-1090
27. Yokel RA, Fredenburg AM, Durbin PW, Xu J, Rayens MK, Raymond KN (2000) J Pharm Sci 89:545-555
28. Carrano CJ, Raymond KN (1979) J Am Chem Soc 101:5401-5404
29. Kretchmar S, Raymond KN (1986) J Am Chem Soc 108:6212-6218
30. Turcot I, Stintzi A, Xu JD, Raymond KN (2000) J Biol Inorg Chem 5:634-641
31. Kontoghiorghes GJ, Evans RW (1985) FEBS Lett 189:141-144
32. Harris WR (1984) J Inorg Biochem 21:263-276
33. Konopka K, Bindereif A, Neilands JB (1982) Biochemistry 21:6503-6508
34. Harris WR, Rezvani AB, Bali PK (1987) Inorg Chem 26:2711-2716
35. Aisen P, Leibman A (1972) Biochim Biophys Acta 257:311-323
36. Stintzi A, Raymond KN (2000) J Biol Inorg Chem 5:57-66
37. Ford S, Cooper RA, Evans RW, Hider RC, Williams PH (1988) Eur J Biochem 178:477-481
38. Hissen AHT, Moore MM (2005) J Biol Inorg Chem 10:211-220
39. Baldwin D (1980) Biochim Biophys Acta 623:183-198
40. Hamilton DH, Turcot I, Stintzi A, Raymond KN (2004) J Biol Inorg Chem 9:936-944
41. Thompson CP, Grady JK, Chasteen ND (1986) J Biol Chem 261:13128-13134
42. Raymond KN, Telford JR (1995) In: Kessissoglou DP (ed) Bioinorganic chemistry an inorganic perspective of life. Kluwer, Dordrecht, pp 25-37
43. Raymond KN, Bryan BL (1995) In: Kessissoglou DP (ed) Bioinorganic chemistry an inorganic perspective of life. Kluwer, Dordrecht, pp 13-24
44. Hershko C, Link G, Konijn AM (2002) In: Templeton DM (ed) Molecular and cellular iron transport. Dekker, New York, pp 775-816
45. Turcot I, Stintzi A, Xu J, Raymond KN (2000) J Biol Inorg Chem 5:634-641
46. Bali PK, Harris WR, Nesset-Tollefson D (1991) Inorg Chem 30:502-508
47. Bali PK, Harris WR (1989) J Am Chem Soc 111:4457-4461
48. Leibman A, Aisen P (1979) Blood 53:1058-1065
49. Baker EN, Baker HM, Kidd RD (2002) Biochem Cell Biol 80:27-34
50. He QY, Mason AB (2002) In: Templeton DM (ed) Molecular and cellular iron transport. Dekker, New York, pp 95-124
51. He QY, Mason AB, Tam BM, MacGillivray RTA, Woodworth RC (1999) Biochemistry 38:9704-9711
52. Zak O, Tam BM, MacGillivray RTA, Aisen P (1997) Biochemistry 36:11036-11043
53. Bali PK, Aisen P (1991) Biochemistry 30:9947-9952
54. Xu JD, Raymond KN (1994) In: Bergeron RJ, Brittenham JM (eds) The development of iron chelators for clinical use. CRC, Boca Raton, pp 307-327
55. Schwarzenbach G, Schwarzenbach K (1963) Helv Chim Acta 46:1390-1400
56. Motekaitis RJ, Martell AE (1991) Inorg Chim Acta 183:71-80
57. Harris WR, Carrano CJ, Cooper SR, Sofen SR, Avdeef A, McArdle JV, Raymond KN (1979) J Am Chem Soc 101:6097-6104
58. Rodgers SJ, Lee C, Ng CY, Raymond KN (1987) Inorg Chem 26:1622-1625